A pilot study of estrogen receptor (ER) expression in pancreatic ductal adenocarcinoma (PDAC)
Background: Pancreatic ductal adenocarcinoma (PDAC) is the most common pancreatic neoplasm with 5-year survival as low as 6%. It is therefore imperative to explore potential treatment avenues to improve survival in these groups of patients. Anti-estrogenic hormone therapy (AEHT) is well-tolerated an...
Saved in:
Main Authors: | Chan, Kai Siang, Ho, Bernard Chi Shern, Shelat, Vishal G. |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Article |
Language: | English |
Published: |
2022
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/160819 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Serum estrogen receptor bioactivity and breast cancer risk among postmenopausal women
by: Lim, V.W., et al.
Published: (2014) -
Differential Global Effects of Selective Estrogen Receptor Modulators on Estrogen Receptor Binding and Transcriptional Regulation
by: LEE YEW KOK
Published: (2011) -
Functional Interactions between the Progesterone Receptor and Estrogen Receptor in Breast Cancer Cells
by: ZHENG ZEYI
Published: (2010) -
Prognostic implications of Estrogen receptor pattern of both tumors in contralateral breast cancer
by: Sandberg, M.E.C., et al.
Published: (2014) -
Dual activation of estrogen receptor a and aryl hydrocarbon receptor by the prenylflavone, Icaritin restrict breast cancer cell growth and destabilize estrogen receptor a protein
by: TIONG CHI TZE
Published: (2011)